Lung Cancer News

The FDA granted fast track designation to poziotinib for previously treated patients with non-small cell lung cancer and HER2 exon 20 mutations, according to a press release from the drug’s manufacturer.

The U.S. Preventive Services Task Force issued its final guidance on lung cancer screening, lowering the age to start screening to 50 years and the required smoking history to 20 pack-years.

A randomized phase 3 trial designed to evaluate canakinumab plus chemotherapy for advanced non-small cell lung cancer failed to meet its primary endpoint of OS, according to the agent’s manufacturer.

Merck voluntarily withdrew pembrolizumab’s indication in the United States for treatment of certain patients with metastatic small cell lung cancer.

A newly developed machine learning-based model successfully predicted risk for malignancy in patients with multiple pulmonary nodules, researchers reported in Clinical Cancer Research.

Results from a prospective, multicenter study demonstrate feasibility and safety of robotic bronchoscopy in patients with peripheral pulmonary lesions, researchers reported in Chest.

The FDA approved cemiplimab-rwlc monotherapy as first-line treatment for certain patients with advanced non-small cell lung cancer.

A revised U.S. Preventive Services Task Force guideline could lead to increased lung cancer screening rates among women and racial and ethnic minority populations, according to a study published in JAMA Network Open.

The FDA granted priority review to sotorasib for treatment of certain patients with non-small cell lung cancer.

Only about half of Medicare beneficiaries who underwent surgery for cancer achieved optimal outcomes, according to study results published in Journal of the American College of Surgeons.